BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 11002358)

  • 1. Evaluating the function of hippocampal subregions with high-resolution MRI in Alzheimer's disease and aging.
    Small SA; Nava AS; Perera GM; Delapaz R; Stern Y
    Microsc Res Tech; 2000 Oct; 51(1):101-8. PubMed ID: 11002358
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mapping local hippocampal changes in Alzheimer's disease and normal ageing with MRI at 3 Tesla.
    Frisoni GB; Ganzola R; Canu E; Rüb U; Pizzini FB; Alessandrini F; Zoccatelli G; Beltramello A; Caltagirone C; Thompson PM
    Brain; 2008 Dec; 131(Pt 12):3266-76. PubMed ID: 18988639
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Aging of memory mechanisms].
    Lamour Y; Bassant MH; Potier B; Billard JM; Dutar P
    C R Seances Soc Biol Fil; 1994; 188(5-6):469-86. PubMed ID: 7780790
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MRI and CSF studies in the early diagnosis of Alzheimer's disease.
    de Leon MJ; DeSanti S; Zinkowski R; Mehta PD; Pratico D; Segal S; Clark C; Kerkman D; DeBernardis J; Li J; Lair L; Reisberg B; Tsui W; Rusinek H
    J Intern Med; 2004 Sep; 256(3):205-23. PubMed ID: 15324364
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discriminating accuracy of medial temporal lobe volumetry and fMRI in mild cognitive impairment.
    Jauhiainen AM; Pihlajamäki M; Tervo S; Niskanen E; Tanila H; Hänninen T; Vanninen RL; Soininen H
    Hippocampus; 2009 Feb; 19(2):166-75. PubMed ID: 18777563
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Changes in hippocampal connectivity in the early stages of Alzheimer's disease: evidence from resting state fMRI.
    Wang L; Zang Y; He Y; Liang M; Zhang X; Tian L; Wu T; Jiang T; Li K
    Neuroimage; 2006 Jun; 31(2):496-504. PubMed ID: 16473024
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Cerebral imaging in healthy aging: contrast with Alzheimer disease].
    Desgranges B; Kalpouzos G; Eustache F
    Rev Neurol (Paris); 2008 May; 164 Suppl 3():S102-7. PubMed ID: 18675034
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cholinergic challenge in Alzheimer patients and mild cognitive impairment differentially affects hippocampal activation--a pharmacological fMRI study.
    Goekoop R; Scheltens P; Barkhof F; Rombouts SA
    Brain; 2006 Jan; 129(Pt 1):141-57. PubMed ID: 16251213
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hippocampal shape analysis in Alzheimer's disease: a population-based study.
    Scher AI; Xu Y; Korf ES; White LR; Scheltens P; Toga AW; Thompson PM; Hartley SW; Witter MP; Valentino DJ; Launer LJ
    Neuroimage; 2007 May; 36(1):8-18. PubMed ID: 17434756
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Verbal episodic memory impairment in Alzheimer's disease: a combined structural and functional MRI study.
    Rémy F; Mirrashed F; Campbell B; Richter W
    Neuroimage; 2005 Mar; 25(1):253-66. PubMed ID: 15734360
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The neural correlates of verbal short-term memory in Alzheimer's disease: an fMRI study.
    Peters F; Collette F; Degueldre C; Sterpenich V; Majerus S; Salmon E
    Brain; 2009 Jul; 132(Pt 7):1833-46. PubMed ID: 19433442
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 3D comparison of hippocampal atrophy in amnestic mild cognitive impairment and Alzheimer's disease.
    Apostolova LG; Dinov ID; Dutton RA; Hayashi KM; Toga AW; Cummings JL; Thompson PM
    Brain; 2006 Nov; 129(Pt 11):2867-73. PubMed ID: 17018552
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Three-dimensional surface mapping of hippocampal atrophy progression from MCI to AD and over normal aging as assessed using voxel-based morphometry.
    Chételat G; Fouquet M; Kalpouzos G; Denghien I; De la Sayette V; Viader F; Mézenge F; Landeau B; Baron JC; Eustache F; Desgranges B
    Neuropsychologia; 2008; 46(6):1721-31. PubMed ID: 18289618
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mapping hippocampal and ventricular change in Alzheimer disease.
    Thompson PM; Hayashi KM; De Zubicaray GI; Janke AL; Rose SE; Semple J; Hong MS; Herman DH; Gravano D; Doddrell DM; Toga AW
    Neuroimage; 2004 Aug; 22(4):1754-66. PubMed ID: 15275931
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multi-parametric classification of Alzheimer's disease and mild cognitive impairment: the impact of quantitative magnetization transfer MR imaging.
    Kiefer C; Brockhaus L; Cattapan-Ludewig K; Ballinari P; Burren Y; Schroth G; Wiest R
    Neuroimage; 2009 Dec; 48(4):657-67. PubMed ID: 19607926
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functional MRI for studying episodic memory in aging and Alzheimer's disease.
    Corkin S
    Geriatrics; 1998 Sep; 53 Suppl 1():S13-5. PubMed ID: 9745629
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cognitive dysfunction, hippocampal atrophy and glucocorticoid feedback in Alzheimer's disease.
    Elgh E; Lindqvist Astot A; Fagerlund M; Eriksson S; Olsson T; Näsman B
    Biol Psychiatry; 2006 Jan; 59(2):155-61. PubMed ID: 16125145
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vivo neuropathology of the hippocampal formation in AD: a radial mapping MR-based study.
    Frisoni GB; Sabattoli F; Lee AD; Dutton RA; Toga AW; Thompson PM
    Neuroimage; 2006 Aug; 32(1):104-10. PubMed ID: 16631382
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MRI-derived entorhinal volume is a good predictor of conversion from MCI to AD.
    deToledo-Morrell L; Stoub TR; Bulgakova M; Wilson RS; Bennett DA; Leurgans S; Wuu J; Turner DA
    Neurobiol Aging; 2004 Oct; 25(9):1197-203. PubMed ID: 15312965
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hippocampus and entorhinal cortex in mild cognitive impairment and early AD.
    Pennanen C; Kivipelto M; Tuomainen S; Hartikainen P; Hänninen T; Laakso MP; Hallikainen M; Vanhanen M; Nissinen A; Helkala EL; Vainio P; Vanninen R; Partanen K; Soininen H
    Neurobiol Aging; 2004 Mar; 25(3):303-10. PubMed ID: 15123335
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.